Two recent studies suggested that TET3 is required for the growth of human TET2MTAML cells [45, 131], suggesting that IDH1/2 mutations might selectively repress TET2MT myeloid malignancies by 2HG-mediated inhibition of TET3. Here, TET3 is linked to myeloid neoplasm.